[{"address1": "Ole MaalOees Vej 3", "address2": "Copenhagen N", "city": "Copenhagen", "zip": "2200", "country": "Denmark", "phone": "45 70 70 29 80", "website": "https://www.iobiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment that express indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide to target T cells that recognize epitopes derived from Arginase 1, which is an immunoregulatory enzyme highly expressed in difficult-to-treat tumors associated with high levels of myeloid-derived suppressor cells, including renal cell carcinoma, head and neck, breast, pancreatic, ovarian, colorectal, and prostate cancers. In addition, the company develops IO170, a TGF\u00df1 vaccine for the treatment of solid tumors. IO Biotech, Inc. was incorporated in 2014 and is based in Copenhagen, Denmark.", "fullTimeEmployees": 80, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mai-Britt  Zocca Ph.D.", "age": 56, "title": "Founder, President, CEO, Principal Financial Officer & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 908461, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Qasim Iftikhar Ahmad M.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 709800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Inge Marie Svane M.D., Ph.D.", "title": "Founder & Clinical Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Mads Hald Andersen M.D., Ph.D.", "title": "Co-Founder & Scientific Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Anders  Ljungqvist", "title": "Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Per Thor Straten", "title": "Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Faulkner M.B.A.", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Devin Whittemore Smith J.D.", "age": 56, "title": "Secretary, General Counsel & Chief Compliance Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 621800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel G. Mannix Ph.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Faical  Miyara Ph.D.", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.8501, "open": 0.86, "dayLow": 0.8, "dayHigh": 0.8622, "regularMarketPreviousClose": 0.8501, "regularMarketOpen": 0.86, "regularMarketDayLow": 0.8, "regularMarketDayHigh": 0.8622, "payoutRatio": 0.0, "beta": 0.483, "forwardPE": -1.8781395, "volume": 328805, "regularMarketVolume": 328805, "averageVolume": 3731217, "averageVolume10days": 930270, "averageDailyVolume10Day": 930270, "bid": 0.7627, "ask": 0.8544, "bidSize": 2, "askSize": 2, "marketCap": 58105884, "fiftyTwoWeekLow": 0.323, "fiftyTwoWeekHigh": 2.79, "allTimeHigh": 17.88, "allTimeLow": 0.323, "fiftyDayAverage": 0.76666, "twoHundredDayAverage": 1.211405, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 45560884, "profitMargins": 0.0, "floatShares": 43401700, "sharesOutstanding": 71948842, "sharesShort": 2846392, "sharesShortPriorMonth": 2762590, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.0396, "heldPercentInsiders": 0.05145, "heldPercentInstitutions": 0.48106998, "shortRatio": 2.99, "shortPercentOfFloat": 0.0756, "impliedSharesOutstanding": 71948842, "bookValue": 0.013, "priceToBook": 62.123077, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -88349000, "trailingEps": -1.34, "forwardEps": -0.43, "enterpriseToEbitda": -0.496, "52WeekChange": 0.080050826, "SandP52WeekChange": 0.13613915, "quoteType": "EQUITY", "currentPrice": 0.8076, "targetHighPrice": 4.0, "targetLowPrice": 0.39, "targetMeanPrice": 2.46333, "targetMedianPrice": 3.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 30664000, "totalCashPerShare": 0.426, "ebitda": -91802000, "totalDebt": 18119000, "quickRatio": 1.729, "currentRatio": 2.011, "debtToEquity": 1988.913, "returnOnAssets": -0.88579005, "returnOnEquity": -2.40484, "freeCashflow": -49063376, "operatingCashflow": -80996000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IOBT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1636119000000, "corporateActions": [], "postMarketTime": 1765587149, "regularMarketTime": 1765573202, "exchange": "NMS", "messageBoardId": "finmb_1685354464", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "IO Biotech, Inc.", "longName": "IO Biotech, Inc.", "postMarketChangePercent": 5.250124, "postMarketPrice": 0.85, "postMarketChange": 0.042400002, "regularMarketChange": -0.0425, "regularMarketDayRange": "0.8 - 0.8622", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 3731217, "fiftyTwoWeekLowChange": 0.4846, "fiftyTwoWeekLowChangePercent": 1.5003096, "fiftyTwoWeekRange": "0.323 - 2.79", "fiftyTwoWeekHighChange": -1.9824, "fiftyTwoWeekHighChangePercent": -0.7105376, "fiftyTwoWeekChangePercent": 8.005083, "earningsTimestampStart": 1747224300, "earningsTimestampEnd": 1747224300, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.34, "epsForward": -0.43, "epsCurrentYear": -0.97, "priceEpsCurrentYear": -0.8325773, "fiftyDayAverageChange": 0.040940046, "fiftyDayAverageChangePercent": 0.053400528, "twoHundredDayAverageChange": -0.40380502, "twoHundredDayAverageChangePercent": -0.33333609, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-05", "regularMarketChangePercent": -4.99941, "regularMarketPrice": 0.8076, "marketState": "CLOSED", "displayName": "IO Biotech", "trailingPegRatio": null, "__fetch_time": "2025-12-13"}]